Expression of cartilage-derived morphogenetic protein in human intervertebral discs and its effect on matrix synthesis in degenerate human nucleus pulposus cells
Open Access
- 15 September 2009
- journal article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 11 (5) , R137
Abstract
Introduction: Loss of intervertebral disc (IVD) matrix and ultimately disc height as a result of 'degeneration' has been implicated as a major cause of low back pain (LBP). The use of anabolic growth factors as therapies to regenerate IVD matrix, hence restoring disc height and thus reversing degenerative disc disease, has been suggested. Cartilage-derived morphogenetic protein (CDMP) is a growth factor which stimulates proteoglycan production in chondrocyte-like cells and thus could be a useful growth factor for LBP therapies. However, little is known about the expression of CDMP or its receptor in human IVD, nor its effects on human disc cells. Methods: Using immunohistochemistry we investigated the localisation of CDMP in non-degenerate and degenerate human IVDs. Additionally, we investigated the effect of CDMP on aggrecan and type II collagen gene expression and proteoglycan synthesis in nucleus pulposus (NP) cells derived from degenerate IVDs. Results: We demonstrated that CDMP 1 and 2 were expressed in the non-degenerate and degenerate IVD, particularly in cells of the NP. A small decrease in the number of CDMP 1 and 2 immunopositive cells was seen with degeneration. Treatment of human NP cells, (derived from degenerate IVD), with CDMP showed an increase in aggrecan and type II collagen gene expression and increased production of proteoglycan (GAGs). Conclusions: The data suggests that CDMP may be a useful growth factor to stimulate proteoglycan production in the human degenerate IVD and hence the repair of the extracellular matrix.Keywords
This publication has 38 references indexed in Scilit:
- Human disc degeneration is associated with increased MMP 7 expressionBiotechnic & Histochemistry, 2006
- Collagen and Proteoglycan Abnormalities in the GDF-5-Deficient Mice and Molecular Changes When Treating Disk Cells With Recombinant Growth FactorSpine, 2004
- Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral discThe Journal of Pathology, 2004
- Release of active and depot GDF-5 after adenovirus-mediated overexpression stimulates rabbit and human intervertebral disc cellsJournal of Molecular Medicine, 2003
- Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapyThe Journal of Pathology, 2002
- Epidemiology, etiology, diagnostic evaluation, and treatment of low back painCurrent Opinion in Rheumatology, 2001
- Low Back Pain in Relation to Lumbar Disc DegenerationSpine, 2000
- The economic burden of back pain in the UKPain, 2000
- A Cross-Sectional Study Correlating Lumbar Spine Degeneration With Disability and PainSpine, 2000
- Autocrine/paracrine mechanism of insulin‐like growth factor‐1 secretion, and the effect of insulin‐like growth factor‐1 on proteoglycan synthesis in bovine intervertebral discsJournal of Orthopaedic Research, 1996